NCT05281029View on ClinicalTrials.gov

Observational Study Gemigliptin in Patients Aged ≥ 65 Years With Type 2 Diabetes Mellitus

UnknownOBSERVATIONAL

Enrollment

3,000

Participants

Timeline

Start Date

June 24, 2021

Primary Completion Date

October 31, 2023

Study Completion Date

October 31, 2023

Conditions

Type 2 Diabetes Mellitus

Trial Locations (1)

Unknown

RECRUITING

Severance Hospital, Seoul

Sponsors

Lead Sponsor

All Listed Sponsors

lead

LG Chem

INDUSTRY

NCT05281029 - Observational Study Gemigliptin in Patients Aged ≥ 65 Years With Type 2 Diabetes Mellitus | Biotech Hunter | Biotech Hunter